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Abstract
Manganese(II) acetate reacts with phthalic acid (phil2) to give [Mn(ph)]’0.5H20 (1). Reaction of 1 with
1,10-phenanthroline produces [Mn(ph)(phen)]’2H20 (2) and [Mn(ph)(phen)2(H20)]’4HzO (3). Reaction of
isophthalic acid (isophHz) with manganese(II) acetate results in the formation of [Mn(isoph)].2H20 (4). The
addition of the N,N-donor ligands 1,10-phenanthroline or 2,2’-bipyridine to 4 leads to the formation of
[Mn2(isoph)2(phen)3)]-4H20 (5), [(Mn(phen)2(HO)](isoph)2(phen)-12H20 (6) and
{[Mn(isoph)(bipy)]4"2.75bipy}n (7), respectively. Molecular structures of 3, 6 and 7 were determined
crystallographically. In 3 the phthalate ligand is bound to the manganese via just one of its carboxylate
groups in a monodentate mode with the remaining coordination sites filled by four phenanthroline nitrogen
and one water oxygen atoms. In 6 the isophthalates are uncoordinated with the octahedral manganese center
ligated by two phenanthrolines and two waters. In 7 the Isophthalate ligands act as bridges resulting in a
polymeric structure. One of the carboxylate groups is chelating a single manganese with the other binding
two metal centres in a bridging bidentate mode. The phthalate and isophthalate complexes, the metal free
ligands and a number of simple manganes salts were each tested for their ability to inhibit the growth of
Candida albicans. Only the "metal flee" 1,10-phenanthroline and its manganese complexes were found to be
active.
Keywords: crystal structures; phthalic acid; isophthalic acid;
complexes; Candida albicans.
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Introduction
The yeast Candida albicans is a commensal of the human body and is considered to be an important fungal
pathogen. Oppurtunistic infection can lead to the development of vaginal candidosis (thrush), a condition
from which over 75% of women suffer at some stage in their lifetime. Systemic candidosis is often fatal in
immunocompromised patients.
TM The state-of-the-art drugs currently used to treat Candida infections are
often ineffective because of problems with resistence or toxicity and subsequently the search for novel anti-
fungal agents has gathered momentum. A number of publications has appeared in the literature highlighting
the fungicidal activity of novel transition metal complexes.
6 Recently, we have shown that a range of
carboxylate complexes icorporating Copper, Manganese and Cobalt metal centres inhibit the growth of
Candida albicans .7-1 In the present paper we report the synthesis and structural characterisation of three
new manganese(II) complexes derived from either phthalic or isophthalic acid. In addition the in-vitro anti-
Candida activities ofthe compounds are discussed.
Materials and Methods
Chemicals were purchased from commercial sources and used without further purification. Infrared spectra
were recorded in the region 4000-400 cm"l on a Nicolet-400 Impact spectrometer. Magnetic susceptibility
measurements were made using a Johnson Matthey Magnetic Susceptibility balance. [HgCo(SCN)4] was
used as a reference. Conductivity readings were obtained using a Ciba Coming model check-mate 90
conductivity meter. Satisfactory microanalytical data for the complexes were reported by the Microanalytical
Laboratory, University College Cork, Ireland.
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Table 1: Summary of crystal data, data collection, structure solution and refinement details for complexes 3, 5
and 7.
Complex (3) Complex (6) Complex (7)
Complex [Mn(ph)(phen)2 [Mn(phen)2(O)]2 {[Mn(isoph)(bipy)]4
(HEO)]’4H20 (isoph)2(plien)-12I-t20 -2.75bipy}n
Formula CaEH30MnN409 C76HaoMn2NloO24 C99.5on69.9oMn4N13.50016
Description yellow triangular pale yellow pale yellow
prism block plate
Crystal size (mm) 0.625 x 0.35 x 0.20 0.46 x 0.22 x.0.12 0.37 x 0.33 x 0.02
Temperature (K) 153(2) 163(2) 158(2)
a (A) 11.509(3) 16.356(2) 13.419(5)
b (A) 11.990(2) 20.573(3) 22.246(8)
c (A) 13.157(2) 23.304(3) 30.217(10)
a, fl , () 69.096(15),70.957(13), 90, 106.895(4), 90 90, 96.647(6), 90
65.074(18)
U(A3) 1504.7(5) 7503(2) 8960(5)
F(000) 694 3392 3956
Crystal system Triclinic Monoclinic Monoclinic
Space group P- P2/c P2(1 )/n
Z 2 4 4
Densi calc. 1.478 1.441 1.431
(Mg/m)
Ia (ram) 0.502 0.423 0.627
Tmax, Tm 0.8848, 0.8299 1.000, 0.874 0.697, 1.000
0 range () 2.20 to 25.00 2.37 to 26.41 1.97 to 24.00
Index ranges 12<h<0 17<h<20 15<h< 14
13<k<12 -24<k<25 -25<k<20
-15<1<14 -27<1<11 -34<1<15
Reflections 5455 32135 45429
collected
Independent 5173 14452 14060
reflections
Rint 0.0211 0.0427 0.0765
Data/restraints/ 5173 / 0 415 14452 / 0 / 1009 14060 142/1201
parameters
GooF on F 1.062 0.854 0.679
R1, wR2 [I> 20(/)] 0.0444, 0.0973 0.0429, 0.0915 0.0491, 0.1188
R1, wR2 [all data] 0.0684, 0.1068 0.1025, 0.1005 0.1663, 0.1369
Deposition No.s CCDC 151284 CCDC 151285 CCDC 151286
The crystal data for complexes 3, 6 and 7 are summarised in Table 1. Data sets for [Mn(ph)(phen)2(H-
20)]’4H20 (3) were collected on a Siemens P4 diffractometer whereas those for
[(Mn(phen)2(H20)2]2(isoph)2(phen)’12H20 (6) and {[Mn(isoph)(bipy)]4"2.75bipy}n (7) were collected using a
Siemens SMART CCD diffractometer. All the data for the structures were corrected for Lorentz,
polarization and absorption effects. All three structures were solved by Direct methods and refined by full
matrix least-squares on F
2 using all of the data. All the non-hydrogen atoms were refined with anisotropic
atomic displacement parameters and hydrogen atoms bonded to carbon atoms were inserted at calculated
positions. For 3 and 6 Hydrogen atoms bonded to oxygen were located from difference Fourier maps and not
further refined. In 6 one of the solvate water molecules was disordered and refined with partial occupancy of
two sites (OI6W 25%, O16’ 75%), the hydrogen atoms associated with this molecule were not inserted. As
described below, the structure of 7 consists of a polymeric chain with the uncoordinated bipy groups
occupying voids in the lattice. The structure can be solved and the polymeric chain refined in a smaller cell
(U 4480 A"3, space group C2/c, Rin 0.042) but we could not satisfactorily model the lattice bipy using
this cell. In the larger, P2/n cell, uncoordinated bipy molecules were located at three independent sites, two
of these were refined without difficulty but some constraints were applied to the third which was refined with
75% occupancy using regular hexagonal geometry for the two six-membered rings. The two nitrogen atoms
were not clearly distinguished in the third bipy molecule and all the atoms were refined as carbon. It seems
probable that the lattice bipy molecules render the structure formally incommensurate.
All the non-hydrogen atoms were refined with anisotropic atomic displacement, hydrogen atoms were
inserted at calculated positions with their isotropic displacement parameters riding on Uij of their carrier
atoms (except for those on the partial occupancy bipy molecule, which were not included).
All programs used in the structure solution and refinement are contained in the SHELXL97 package.
1"
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IMn(ph)l-0.51-120 (1): To a solution of phil2 (1.25 g, 7.52 mmol) in ethanol (100cm3) was added manganese
(II) acetate (2.00 g, 8.25 mmol), and the mixture was refluxed for 2h. The product formed as a colourless
solid. The reaction mixture was allowed to cool to room temperature and the product was filtered off. The
compound was washed with two portions of ethanol and then dried in air. Yield: 1.73 g (92.12%). Complex 1
was soluble in dist. H20, partially soluble in warm ether and insoluble in EtOH, MeOH, acetone and
chloroform. Found: C, 42.40;H, 1.92. Calc: C, 42.13;H, 2.21%. IR: 3408.96, 3073.13, 1555.22, 1488.06,
1420.22, 1360.45, 1259.70, 1145.52, 1091.79, 1051.49, 950.75, 856.32, 829.85, 807.45, 735.06, 694.75,
648.51,594.78 cm. laer 5.91 B.M. AM (H20) 116.21 Scm2mol".
[Mn(ph)(phen)l-2H20 (2) and [Mn(ph)(phen)(HO)l.4HO (3): Comp31ex 1 (0.5 g, 2.19 mmol) and 1,10-
phenanthroline (0.81 g, 4.08 mmol) were refluxed in ethanol (50 cm ) for 2h. Upon cooling to room
temperature the resulting suspension was filtered off to give a yellow powder and a yellow solution. The
yellow product (complex 2) was filtered off and then air-dried. Yield: 0.38 g, (40.18%). Complex 2 was
partially soluble in warm dist. H20, EtOH, MeOH, acetone, ether and chloroform. Found: C, 55.5;H, 3.52;N,
6.48. Calc: C, 55.18;H, 3.70;N, 6.43%. IR: 3408.96, 3073.13, 1548.51, i514.93, 1407.46, 1145.52, 1111.94,
1085.07, 856.72, 769.40, 729.10, 695.52, 648.51 cm. [aeff 5.94 B.M. AM (H20) 56.50 Scm2mol"r.
The yellow filtrate was set aside to evaporate slowly. Upon standing at room temperature for a week complex
3 deposited as yellow crystals. The crystals were filtered off and air-dried. Yield: 0.38 g, (26.11%). Found:
C, 59.81; H, 4.04; N, 8.57. Calc: C, 57.40; H, 4.52; N, 8.37%. IR: 3415.24, 3045.79, 1608.30, 1574.71,
1507.54, 1420.22, 1379.91, 1218.70, 1144.81, 1097.79, 861.20, 846.73 761.92, 728.34, 721.75, 636.45 cm".
laff 5.87 B.M. AM (EtOH) 8.20 Scmmol".
[Mn(isoph)l.2HO (4): To a solution of isophH2 (1.10 g, 6.62 mmol) in ethanol (100 cm3) was added
manganese (II) acetate (1.78 g, 7.26 mmol), and the mixture was refluxed for 2h. The product formed as a
colourless solid. The reaction mixture was allowed to cool to room temperature and then filtered. The
product was washed with two portions of ethanol and dried in air. Yield: 1.64 g (97.12%). Complex 4 was
soluble in warm HzO, partially soluble in warm MeOH, and insoluble in EtOH, acetone, ether and chloroform.
Found: C, 37.35;H, 2.90. Calc: C, 37.67;H, 3.16%. IR 3314.48, 2280.60, 1648.60, 1615.67, 1547.84,
1481.34, 1454.48, 1380.60, 1165.67, 1085.07, 1004.48, 944.03, 816.42, 735.82, 695.52, 541.04, 447.01 cm.
2
laff 5.74 B.M. AM (H20) 147.17 Scm mol.
Mn(OAc)2 "4H20 + phil2
EtOH
Mn(ph)- 0.5H20 (1)
Phen
EtOH
[Mn(ph)(phen)]-2H20 (2) + [Mn(ph)(phen)2(H20)]-4H20 (3)
Scheme 1
IMn2(isoph)_(phen)3l-4H20 (5) and [Mn(phen)2(H.O)212(isoph)2(phen)’12H20 (6): Complex 4 (0.5 g, 1.96
retool) and 1,10-phenanthroline (0.77 g, 3.92 mmol) were stirred for 4h in deionised water (100 cm). The
resulting yellow suspension was filtered yielding a yellow powder and a yellow solution. The powder
(Complex 5) was collected and allowed to dry in air. Yield: 1.02 g (49.54%). Complex 5 was soluble in
MeOH and acetone, in warm ether, partially soluble in warm EtOH and chloroform, and insoluble in dist.
H20. Found: C, 58.24;H, 3.14;N, 8.6. Calc: C, 59.43;H, 3.84;N, 8.00%. IR: 3550.00, 3476.12, 3415.24,
3052.51, 1642.54, 1608.30, 1575.37, 1514.26, 1447.76, 1427.61 1383.63, 1367.161219.40, 1145.52,
2 104.50, 1078.36, 856.72, 755.97, 728.34, 641.79 cm-. e= 5.43 B.M0 AM (MeOH) 2.19 Scm mol. The
yellow filtrate was reduced on a hot plate and subsequently upon standing at room temperature for a week
complex 6 deposited as yellow crystals. The crystals were filtered off and air-dried. Yield: 0.12 g, (7.52%).
Found: C, 58.16, H, 3.66, N, 9.61 Calc: C, 56.09, H, 4.95, N, 8.61%. [,R: 3415.67, 1602.24, 1561.94,
1514.93, 1420.90, 367.16, 863.43, 43.28, 749.25, 729. 0 cm-. laeff 6.16 B.w.
{[Mn(isoph)(bipy)14-2.75bipy}. (7): To a solution of 4 (0.51 g, 2.00 retool) in deionised water (100 cm3)
was added 2, 2’-bipyridine (0.92 g, 5.89 retool) and the mixture was stirred for 4h. The resulting green
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solution gave yellow crystals (complex 7) after standing at room temperature for one month. The crystals
were filtered off, washed with two small portions of water and then allowed to dry in air. Yield: 0.41 g
(29.51%). Complex 7 was partially soluble in warm ether and insoluble in dist, H20, EtOH, MeOH, acetone
and chloroform. Found: C, 61.46, H, 3.64, N, 9.73. Calc: C, 61.92, H, 3.63, N, 9.79%. IR: 3402.24, 3059.70,
1662.69, 1602.24, 1561.94, 1475.70, 1441.04, 1432.67,1380.60, 1320.15, 1273.13, 1246.27, 1158.96,
1098.51, 1058.21, 1017.91,917.16, 776.12, 755.97, 722.39 Cm laeff 5.81 B.M. AM (Ether) 0 Scm2mol.
Biological Studies
Candida albicans isolate was obtained commercially from Oxid Culti-loops (ATCC 10231) .The isolate was
stored on Sabouraud dextrose agar (SDA) plates at 4 C.
Suspensions of the test complexes were p.repared by grinding them to a fine powder (0.02 g) followed by
addition to sterile distilled water (100 cm3). This process yielded stock suspensions of 200 lag cm"3. These
suspensions were furthered diluted to 100 lag cmL
Susceptibility testing Method: RPMI-1640 broth medium (Sigma R 7755) was used for the anti-Candida
susceptibility testing. The medium (1 dm3) was supplemented with L-glutamine (0.3 g) and
morpholinepropanesulfonic acid (MOPS) (34.6 g) and was then adjusted to pH 7.0 using sterile NaOH (0.2
M). The broth microdilution reference method was used NCCLS publication M27-P.
13 Prior to testing, yeast
cells were grown on Sabouraud dextrose agar (SDA) at 37 C for 24 h. Cell suspensions were prepared in
sterile phosphate buffered saline (5 cm3) to a density of McFarland standard. A 1:100 dilution of these cell
suspensions were made in RPMI-1640 medium so that the cell concentration of the final inoculum was 3.5 x
104- 5.0 x 105 cells cm3. The prepared cells suspension (900 lad was dispensed into sterile test tubes and to
this was added the test complex solutions (100lal) to yield working solutions of the test complexes of
concentration 10 lag cm3. The test tubes were then incubated in a shaking water bath for 24 h at 37 C with
continuous shaking. Each complex was assessed in triplicate and three independent experiments were
performed.
Mri’OAc) "4H20 + isoohH
[Mri’isoth)] 2H O (4)
IMn9(isooh) (oben) .s]"4HO (5) I-Mn(isot)h)(biov)] 4.2.75biovl n (7)
[Mn(DI’K’} 2(H20)212 (isooh)2(ohen) 12H O
Scheme 2
Results and Discussion
Reaction pathways to the complexes 1-7 are shown in Scheme and Scheme 2. Manganese(ll) acetate
reacted smoothly with phthalic acid (phH2) to give [Mn(ph)]-0.5H20 (1) as a colourless powder. Reaction of
1 with 1,10-phenanthroline in ethanol yielded [Mn(ph)(phen)].2H20 (2) as a yellow precipitate and [Mn(ph)
(phen)z(H20)]-4H20 (3) deposited as yellow crystals from the reaction filtrate. Reaction of isophthalic acid
(isophH2) with manganese(lI) acetate resulted in the formation of [Mn(isoph)].2H20 (4) as a colourless
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powder. The addition of the N,N-donor ligands 1,10-phenanthroline or 2,2’-bipyridine to 4 lead to the
formation of [Mn2(isoph)2(phen)3]’4H20 (5), [(Mn(phen)2(H20)2]2(isoph)2(phen)’12H20 (6) and
{[Mn(isoph)(bipy)]4.2.75bipy}, (7), respectively
’’02
02t
O22
024
023
Figure 1: Structure of [Mn(ph)(phen)2(H,.O)]-4H20 (3)
The X-ray structure of 3 is shown in Figure and Figure 2 and selected bond lengths and angles for the
complex are presented in Table 2. The asymmetric unit consists of [Mn(ph)(phen)2(H20)] (Figure 1). The two
phenanthrolines are co-ordinated to the Manganese atom in a bidentate way while the phthalate anion is
bound to the metal through only one carboxylate oxygen in a monodentate mode. A water molecule occupies
the sixth co-ordination site.
The carboxylate oxygen (O21), the coordinated water oxygen (OIW) and the lattice water oxygens (O2W-
O5W) are all involved in Hydrogen bonding (Table 3). The O4W is hydrogen bonded to the co-ordinated
carboxylate oxygen (O21) and to another molecule of water (symmetry related). The O5W is hydrogen
bonded in the same manner to the upper O3W and to another carboxylate oxygen (symmetry related). The
O2W is hydrogen bonded to two different carboxylate groups, and O3W to O2W and the symmetry generated
O3W. The co-ordinated water molecule OIW is involved as well in hydrogen bonding to 024 and 023
(symmetry generated). A number of water lattice molecules form columns that run through the middle of the
unit cell (Figure 2).
279Michael Devereux et al. Synthesis and Biological Activity ofManganese(ll)
Complexes ofPhthalic andIsophthalic Acid
Figure 2: The unit cell for [Mn(ph)(phen)E(H20)]-4H20 (3)
The X-ray structure of 6 is shown in Figure 3 and selected bond lengths and angles for the complex are
presented in Table 4. The asymmetric unit consists of two independent [Mn(phen)(H_O)2]
2/ cations, two
independent isophthalate anions [isoph]-, a non-coordinated phenanthroline molecule and twelve
uncoordinated lattice water molecules. (Figure 3)
The two co-ordinated H20 molecules of each cation are hydrogen bonded (Table 5) to a carboxy|ate group
belonging to one ofthe isophthalate anions (O1W-O22, O2W-O21, O3W-O31 and O4w-O32).
An important aspect in the crystal is the presence of non-co-ordinate phenanthroline molecule intercalated
between two phenanthroline groups on adjacent manganese centres. The non-co-ordinate phenanthroline
molecule brings n-n stacking to the crystal, the interplanar distances for the n-n stacking are ca. 3.4A. The
intercalated phenanthroline molecule is also involved in hydrogen bonding (Table 5) to one of the co-
ordinated water molecules of each cation (NIE-O3W 2.851, N2E-O2W 2.837A) (Figure 4). These
phenathroline molecules are stacked parallel to the ab plane and perpendicular to the plane containing the
phthalate anions (Figure 5).
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Table 2. Selected bond lengths [A] and angles [o] for complex 3.
Mn-O(1W) 2.097(2)
Mn-O(21) 2.133(2)
Mn-N(2A) 2.265(3)
Mn-N(1B) 2.280(3)
Mn-N(1A) 2.280(3)
MnoN(2B) 2.311(3)
O(1W)-Mn-O(21) 92.14(8)
O(1W)-Mn-N(2A) 106.64(9)
0(21)-Mn-N(2A) 103.67(9)
O(1W)-Mn-N(1B) 89.78(9)
0(21)-Mn-N(1B) 90.77(9)
N(2A)-Mn-N(1B) 157.43(9)
O(1W)-Mn-N(1A) 86.96(9)
0(21)-Mn-N(1A) 176.46(9)
N(2A)-Mn-N(1A) 73.34(9)
N(1B)-Mn-N(1A) 92.66(9)
O(1W)-Mn-N(2B) 162.25(9)
0(2I)-M .-N(2B) 90.79(9)
N(2A)-Mn-N(2B) 89.63(9)
N(1B)-Mn-N(2B) 72.68(9)
N(1A)-Mn-N(2B) 91.10(9)
Table 3. Hydrogen bonds for complex 3 [A and o].
D-H...A d(D-H) d(H...A) d(D...A)
O(1W)-H(1WA)...O(24)
0(2W)-H(2WA)...O(24)#
0(3W)-H(3WA)...O(2W)
0(2W)-H(2WB)...0(22)#2
O(5W)-H(SWB)...0(22)#3
O(l W)-H(1 WB)...O(23)#4
O(4W)-H(4WA)...O(2 l)
O(4W)-H(4WB)...O(4W)#3
O(3W)-H(3WB)...O(3W)#5
O(5W)-H(SWA)...O(3W)
0.93 1.85 2.760(3)
0.86 1.96 2.814(3)
0.98 1.77 2.730(3)
0.89 1.98 2.848(3)
0.91 1.94 2.764(4)
0.91 1.72 2.625(3)
0.99 1.91 2.844(3)
0.77 2.09 2.783(6)
0.85 1.94 2.795(6)
0.94 2.03 2.683(4)
Symmetry transformations used to generate equivalent atoms:
# -x+1,-y+l,-z #2 x,y,z+l #3 -x+ 1,-y,-z
#4 -x+1,-y+ ,-z- #5 -x+ ,-y,-z+
<(DHA)
164.3
173.9
166.8
165.0
150.2
173.6
156.3
149.4
174.6
125.4
The X-ray structure of 7 is shown in Figure 6 and selected bond lengths and angles for the complex are presented in
Table 6. The structure consists of interlocked undulating polymeric ribbons running parallel to the c axis. Each
manganese ion is coordinated to one bipy group, one bidentate carboxylate group and two further oxygen donors,
one from each of two 1,3-carboxylate bridges (Figure 6). The diacids are each bonded to three different manganese
ions, using one carboxylate as a bidentate ligand and the other as a bridging group. The manganese/isoph backbone
ofthe polymer is shown in Figure 7.
Figure 8 shows the resulting honeycomb network, with n-stacking parallel to a and the polymer running
parallel to c. The resulting lattice has channels parallel to a where the uncoordinated bipy molecules lie; these
do not appear to have any significant interactions with the rest ofthe structure.
All of the novel complexes (1-7), the metal free ligands and simple salts of manganese were each tested for their
ability to inhibit the growth of Candida Albicans (Table 7). Phthalic acid, isophthalic acid and the simple
manganese salts are all essentially inactive against the pathogen. Furthermore, coordination of the acids to the
metal (complexes 1 and 4) does not result in any significant improvement in their activity. The uncoordinated
bipyridine and again does not prevent the growth of the Candida Albicans and indeed the isophthalate complex
incorporating the bipyridine ligand (complex 7) only exhibits slight fungitoxic activity. The complexes
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incorporating the 1,10-phenanthroline ligand (complexes 2, 3, 5 and 6) dramatically inhibit the growth of the
fungus.
(R)
07W
(R)
013W
OlW
O23 022
02 J
0 09W
04W
015’
012W 015V
OSW O14W
(R) 06W
Table 4.
Figure 3: The asymmetric unit for [Mn(phen)2(HzO)2]2(isoph)2(phen)"12H20 (6)
Selected bond lengths [A] and angles [o] for complex 6.
Mn(1)-O(2W)
Mn(1)-N(ZB)
Mn(1)-N(1A)
Mn(1)-N(1B)
Mn(I)-N(2A)
Mn(2)-O(4W)
O(1W)-Mn(1)-O(2W)
O(1W)-Mn( )-N(2B)
O(2W)-Mn(I)-N(2B)
O(1W)-Mn(1)-N(1A)
O(2W)-Mn(I)-N(1A)
N(2S)-Mn(1)-N(1h)
O(1W)-Mn(1)-N(1B)
O(2W)-Mn(1)-N(1B)
N(2B)-Mn(1)-N(1B)
N(1A)-Mn(1)-N(1B)
O(l W)-Mn(1)-N(2A)
O(2W)-Mn(1)-N(2A)
N(2B)-Mn(I)-N(2A)
N(1A)-Mn(1)-N(2A)
N(1B)-Mn(1).-N(2A)
O(4W)-Mn(2)-O(3W)
O(4W)-Mn(2)-N(I C)
O(3W)-Mn(2)-N(1C)
O(4W)-Mn(2)-N(2D)
O(3W)-Mn(2)-N(2D)
N(I C)-Mn(2)-N(2D)
O(4W)-Mn(2)-N(1D)
2.167(2) Mn(2)-O(3W) 2.149(2)
2.269(2) Mn(2)-N(IC) 2.258(2)
2.273(2) Mn(2)-N(2D) 2.272(2)
2.292(2) Mn(2)-N(1D) 2.288(2)
2.294(2) Mn(2)-N(2C) 2.313(2)
2.1289(19)
88.95(8)
89.50(8)
07.26(8)
11.22(8)
88.45(8)
54.51(9)
61.45(8)
90.34(8)
73.04(8)
87.28(8)
90.36(8)
59.53(8)
93.19(9)
72.77(9)
96.66(8)
87.81(7)
92.61(8)
03.66(8)
09.57(8)
93.15(8)
52.74(9)
90.53(8)
O(3W)-Mn(2)-N(ID)
N(l C)-Mn(2)-N(1D)
N(2D)-Mn(2)-N(1D)
O(4W)-Mn(2)-N(2C)
O(3W)-Mn(2)-N(2C)
N(1C)-Mn(2)-N(2C)
N(2D)-Mn(2)-N(2C)
N(1D)-Mn(2)-N(2C)
164.84(8)
91.46(8)
73.23(9)
163.78(8)
89.13(8)
72.66(8)
86.50(8)
96.45(8)
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Table 5. Hydrogen bonds for complex 6 [A and o].
D-H...A d(D-H) d(H...A) d(D...A) <(DHA)
O(1W)-H(1WA)...O(15W)#l
O(1W)-H(1WB)...O(22)
O(2W)-H(2WA)...N(2E)
O(2W)-H(2WB)...O(21)
O(3W)-H(3WA)...N(1E)
O(3W)-H(3WB)...O(31)
O(4W)-H(4WA)...O(32)
O(4W)-H(4WB)...O(5W)#2
O(5W)-H(5WA)...0(23)
O(5W)-H(5WB)...O(6W)
O(6W)-H(6WA)...O(34)#3
O(6W)-H(6WB)...O(12W)#4
O(7W)-H(7WA)...O(24)
O(7W)-H(7WB)...O(5W)
O(SW)-H(8WA)...O(31)
O(SW)-H(SWB)...O(10W)
O(9W)-H(9WA)...O(32)
O(9W)-H(9WB)...O(14W)#2
O(10W)-H(0WA)...O(21)
O(10W)-H(0WB)...O(16W)#5
O(10W)-H(0WB)...O(16’)#5
O(11W)-H(1WC)...O(33)
O(11W)-H(1 WD)...O(22)#2
O(12W)-H(2WC)...O(8W)#6
O(12W)-H(EWD)...O(9W)
O(laW)-H(aWC)...O(32)#4
O(13W)-H(3WD)...O(23)
O(14W)-H(4WC)...O(11W)#4
O(14W)-H(4WD)...0(23)
O(15W)-H(5WC)...O(33)#3
O(15W)-H(SWD)...O(7W)
O(16W) O(7W)
O(16W) O(10W)#5
O(16’) O(14W)#7
0.93 1.74
0.84 1.81
0.94 1.94
0.88 1.87
0.92 1.98
0.93 1.79
0.89 1.79
0.84 1.84
0.80 2.02
0.96 1.71
1.08 1.64
0.88 1.91
0.83 1.93
0.93 2.00
0.92 1.87
0.85 1.90
0.89 1.96
0.93 1.86
1.06 1.84
0.88 1.80
0.88 2.11
0.97 1.79
1.00 1.81
0.86 1.85
0.82 1.98
1.10 1.94
1.00 2.00
0.97 1.77
0.94 1.87
0.88 1.89
1.06 1.75
2.649(3)
2.647(3)
2.837(3)
2.732(3)
2.851(3)
2.711(3)
2.681(3)
2.678(3)
2.806(3)
2.671(3)
2.694(3)
2.743(3)
2.733(3)
2.825(3)
2.753(3)
2.730(3)
2.853(3)
2.782(3)
2.794(3)
2.679(13)
2.906(5)
2.726(3)
2.789(3)
2.694(3)
2.771(3)
2.988(3)
2.890(3)
2.732(4)
2.801(3)
2.647(3)
2.798(4)
2.92(3)
2.68(1)
2.776(8)
164.4
172.2
160.4
165.0
158.7
172.1
174.7
174.3
169.3
172.0
166.4
158.7
164.2
147.4
160.8
163.7
177.2
170.6
148.2
172.2
150.2
162.4
166.5
167.0
163.3
158.8
146.8
168.6
167.1
142.0
167.1
Symmetry transformations used to generate equivalent atoms:
#1 x,-y+l/2,z-1/2 #2 x+l,y,z #3 x-1,-y+l/2,z+l/2 #4 x-l,y,z
#6-x+l,y-1/2,-z+l/2 #7 x, 1/2-y, l/2+z
#5 -x,-y+l,-z+l
"Metal free" 1,10-phenanthroline showed very high anti-Candida activity and indeed this was only surpassed by
the activity of the phthalate/1,10-phenanthroline complex 2. In this case is thought that the powerful chelating
ligand 1,10-phenanthroline is probably coordinating to metal ions (other than manganese) that are present in trace
quantities in the growth medium and that it is these resulting metal-phenanthroline complexes that are responsible
the observed anti-candida activity of the so called "metal free" phenanthroline. Studies are currently being carried
out in our laboratories to examine this hypothesis.
In conclusion, it would appear that phthalic acid and isophthalic acid whether coordinated or
uncoordinated to manganese do not posses any anti-candida properties. Furthermore the presence of the N, N-
donor ligand bipyridine does not improve the activity of the isophthalate complex. The 1,10-phenanthroline
molecule is a potent anti-candida agent and upon reaction with the phthalate and isophthalate complexes it yields
compounds with comparable fungitoxic activity.
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Figure 4: The n- stacking ofphenanthrolines in [Mn(phen)(H20)2]2(isoph)2(phen)-12H20 (6)
Figure 5: Packing diagram for [Mn(phen)2(HO)](isoph)(phen)"12H.O (6)
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Figure 6: The structure of [Mn(isoph)(bipy)]4 component of complex 7
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Figure 7: The manganese/isoph backbone of {[Mn(isoph)(bipy)]4-2.75bipy}. (7)
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Table 6. Selected bond lengths [A] and angles [o] for complex 7.
Mn(1)-0(53) 2.079(7)
Mn( )-O(61 ) 2.115(5)
Mn(1)-0(52)#1 2.193(6)
Mn(1)-N(1 l) 2.274(6)
Mn(1)-N(12) 2.277(7)
Mn(1)-O(51)#1 2.366(7)
Mn(2)-O(54) 2.108(5)
Mn(2)-O(62) 2.085(7)
Mn(2)-O(72) 2.181 (6)
Mn(2)-N(2 l) 2.290(6)
Mn(E)-N(22) 2.294(6)
Mn(2)-O(71) 2.390(6)
Mn(3)-O(63) 2.202(6)
Mn(3)-O(64)
Mn(3)-O(73)
Mn(3)-O(81)
Mn(3)-N(31)
Mn(3)-N(32)
Mn(4)-O(74)
Mn(4)-O(82)
Mn(4)-O(83)#2
Mn(4)-N(42)
Mn(4)-N(41)
Mn(4)-O(84)#2
2.364(7)
2.088(7)
2.100(5)
2.289(7)
2.291(6)
2.113(5)
2.084(7)
2.188(6)
2.273(6)
2.282(6)
2.410(7)
O(53)-Mn( )-0(61 ) 96.2(2)
O(53)-Mn( )-O(52)# 93.2(2)
0(61)-Mn(1 )-O(52)#1 106.5(2)
O(53)-Mn(1)-N(11) 116.1(3)
O(61)-Mn(1)-N(11) 93.0(2)
O(52)#1-Mn(1)-N(11) 143.0(3)
O(53)-Mn(1)-N(12) 84.9(3)
0(61)-Mn(1)-N(12) 162.7(3)
0(52)#1-Mn(1)-N(12) 90.7(3)
N(11)-Mn(1)-N(I 2) 71.2(3)
O(53)-Mn(1 )-0(51 )#1 150.7(2)
O(61)-Mn(1)-O(51)#1 95.8(2)
O(52)#1-Mn(1)-O(51)# 57.8(2)
N( 11)-Mn(l )-0(51 )# 89.8(2)
N(12)-Mn( )-0(51)# 91.3(3)
O(62)-Mn(2)-O(54) 97.7(2)
O(62)-Mn(2)-O(72) 92.2(2)
O(54)-Mn(2)-O(72) 106.7(2)
O(62)-Mn(2)-N(21) 85.5(3)
O(54)-Mn(2)-N(21 ) 163.1 (2)
O(72)-Mn(2)-N(21) 89.7(2)
O(62)-Mn(2)-N(22) 16.6(3)
O(54)-Mn(2)-N(22) 92.8(2)
O(72)-Mn(2)-N(22) 142.9(3)
N(2 I)-Mn(2)-N(22) 71.1(2)
O(62)-Mn(2)-O(71 ) 149.34(
O(54)-Mn(2)-O(7 ) 95.6(2)
O(72)-Mn(2)-O(71 ) 57.4(2)
N(21 )-Mn(2)-O(71 ) 89.7(2)
N(22)-Mn(2)-O(71 ) 90.1(2)
9)
O(73)-Mn(3)-O(81)
O(73)-Mn(3)-O(63)
O(81)-Mn(3)-O(63)
O(73)-Mn(3)-N(31)
O(81)-Mn(3)-N(31)
O(63)-Mn(3)-N(31)
O(73)-Mn(3)-N(32)
O(8I)-Mn(3)-N(32)
O(63)-Mn(3)-N(32)
N(3 I)-Mn(3)-N(32)
O(73)-Mn(3)-O(64)
O(81)-Mn(3)-O(64)
O(63)-Mn(3)-O(64)
N(31)-Mn(3)-O(64)
N(32)-Mn(3)-O(64)
O(82)-Mn(4)-O(74)
O(82)-Mn(4)-O(83)
O(74)-Mn(4)-O(83)
O(82)-Mn(4)-N(42)
O(74)-Mn(4)-N(42)
O(83)-Mn(4)-N(42)
O(82)-Mn(4)-N(41)
O(74)-Mn(4)-N(41)
O(83)#2-Mn(4)-N(41)
N(42)-Mn(4)-N(41)
O(82)-Mn(4)-O(84)#2
O(74)-Mn(4)-O(84)#2
O(83)#2-Mn(4)-O(84)#2
N(42)-Mn(4)-O(84)#2
N(41)-Mn(4)-O(84)#2
96.8(2)
91.9(2)
106.5(2)
87.1(3)
162.5(2)
90.3(2)
118.3(3)
92.8(2)
142.1(3)
70.5(2)
149.4(2)
94.5(2)
57.6(2)
90.5(2)
89.4(2)
98.6(2)
91.4(2)
107.6(2)
86.2(3)
161.6(2)
89.9(2)
117.7(3)
91.4(2)
142.7(3)
70.9(2)
148.6(2)
95.0(2)
57.4(2)
89.7(2)
90.0(2)
Symmetry transformations used to generate equivalent atoms: #1, l-x, l-y, -z; #2, 3-x, l-y, 1-z
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Figure $: The packing diagram for the structure of {[Mn(isoph)(bipy)]4"2.75bipy}n (7)
Table 7: Anti-candida activity.
Test Compound
control
Phthalic acid
Isophthalic acid
1,10-phenanthroline
2,2’-bipyridine
MnCI2
Mn(NO3)2
Mn(OAc)
Mn(SO4)
[Mn(ph)].0.5HO 1
[Mn(ph)(phen)].2(HO) 2
[Mn(ph)(phen)(H20)].4HO 3
[Mn(isoph)]-2HO 4
[Mn(isoph)(phen)3]-4H20 5
[Mn(phen)(HO)]2(isoph)(phen).12H20 6
{[Mn(isoph)(bipy)].4"2.75HO}n 7
%CeilGrowth
Isolate
100
100+ 8
108+ 12
23+ 2
114+6
110+5
133 +7
117 + 10
101 + 9
113+7
19+2
30+2
131 + 15
26+3
28+2
90+ 10
The compounds were tested at concentrations of 10 tg cm
"3 ofaqueous RPMI medium. The complexes 5
and 7 were insoluble in water and were used as suspensions. Yeast cells were grown for 24h at 37 C.
Results are presented as% cell growth and the effectiveness ofthe compounds are compared to the
growth ofthe control (no compound added).
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